Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.

Investlytic score: 2/5 criteria met.
- ❌ Price trend failed
- ❌ Growth failed
- ❌ Debt failed
- ✅ P/E passed
- ✅ Correction passed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2018 → 2019: 40.70%
Price change 2019 → 2020: 2.63%
Price change 2020 → 2021: -25.15%
Price change 2021 → 2022: -57.27%
Price change 2022 → 2023: 57.33%
Price change 2023 → 2024: 19.67%
Price change 2024 → 2025: -4.75%
Price change 2025 → 2026: -2.15%
Price change 2026 (year to date): -1.64%
Financial growth
Revenue CAGR (8 years): -0.23%
Earnings CAGR (8 years): -2.76%
Growth status: weak or negative trend (<1%/yr) in revenue and earnings.
Debt
Debt-to-equity ratio: 0.74
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 13.64
P/E < 25.0 (maximum threshold).
Correction (6 months)
Current correction: 17.52% from the high over 6 months.
Correction between 10.0% and 20.0% (target range).
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="PHIA.AS" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| Koninklijke Philips N.V. | 17.6 | 0.74 | −2.3 % | 🔒 |
| Illumina, Inc. | 42.4 | 0.94 | +11.0 % | – |
| ResMed Inc. | 20.4 | 0.14 | +10.8 % | ★ 5/5 |
| Sartorius Stedim Biotech S.A. | 51.0 | 0.64 | +13.7 % | – |
| Viatris Inc. | 7.9 | 1.00 | +6.6 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Key reported figures
Revenue, net income and net margin reported by Koninklijke Philips N.V. over the latest fiscal years.
| Fiscal year | Revenue | Net income | Net margin | Revenue growth |
|---|---|---|---|---|
| 2020 | 21.8 bn | 1.3 bn | 6.1 % | n/a |
| 2021 | 19.1 bn | 3.7 bn | 19.4 % | -12.2 % |
| 2022 | 19.9 bn | -1.8 bn | -9.0 % | +3.9 % |
| 2023 | 20.3 bn | -520 m | -2.6 % | +1.9 % |
| 2024 | 20.1 bn | -783 m | -3.9 % | -0.8 % |
| 2025 | 19.9 bn | 999 m | 5.0 % | -1.0 % |
Amounts converted to USD. Source: published annual accounts, collected on 06/11/2026.
Accounts and financial health
Balance sheet and cash flow published by Koninklijke Philips N.V. over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash and investments | 2.3 bn | 1.2 bn | 1.9 bn | 2.4 bn | 2.8 bn |
| Total Debt | 7.0 bn | 8.2 bn | 7.7 bn | 7.5 bn | 8.1 bn |
| Net Debt | 4.7 bn | 7.0 bn | 5.8 bn | 5.1 bn | 5.3 bn |
| Equity | 14.4 bn | 13.2 bn | 12.0 bn | 12.0 bn | 11.0 bn |
| Total assets | 31.0 bn | 30.7 bn | 29.4 bn | 29.0 bn | 26.9 bn |
| Operating cash flow | 1.6 bn | -173 m | 2.1 bn | 1.6 bn | 1.2 bn |
| Investments (capex) | 763 m | 806 m | 345 m | 676 m | 668 m |
| Free cash-flow | 866 m | -979 m | 1.5 bn | 893 m | 903 m |
| Share buybacks | 1.6 bn | 187 m | 662 m | 411 m | 0 |
| Dividends paid | 482 m | 412 m | 2.0 m | 1.0 m | 328 m |
Amounts in EUR, currency of the published accounts.
Trailing 12-month ratios
Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 09/11/2026.
Valuation and competitors
Koninklijke Philips N.V. compared with its sector on the same exchange and with its main competitors.
Direct competitors
| Company | Market cap (USD) | P/E | Net margin |
|---|---|---|---|
| Koninklijke Philips N.V. | 26.5 bn | 15.6 | 5.0 % |
| Siemens Healthineers AG SHL.DE | 53.7 bn | 18.3 | 9.2 % |
| GE HealthCare Technologies Inc. GEHC | 34.6 bn | 16.8 | 10.1 % |
| Medtronic plc MDT | 123 bn | 17.5 | 13.9 % |
| Abbott Laboratories ABT | 184 bn | 20.4 | 14.7 % |
| Stryker Corporation SYK | 112 bn | 21.8 | 12.9 % |
| Boston Scientific Corporation BSX | 60.8 bn | 13.5 | 14.4 % |
| Edwards Lifesciences Corporation EW | 53.0 bn | 34.1 | 17.7 % |
| DexCom, Inc. DXCM | 30.7 bn | 32.3 | 17.9 % |
Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 06/11/2026. Competitors: comparable companies named by the data provider.
Analyst consensus and forecasts
What the financial analysts covering Koninklijke Philips N.V. publish: ratings, price targets and earnings forecasts.
Breakdown of ratings
Price targets: published for companies listed in the United States only.
Analyst forecasts
| Fiscal year | Revenue | Net income | Expected EPS (range) | P/E on this EPS | Analysts |
|---|---|---|---|---|---|
| 2026 | 18.0 bn | 1.5 bn | 1.63 (1.36 / 1.73) | 14.9 | 12 |
| 2027 | 18.8 bn | 1.6 bn | 1.66 (1.51 / 1.76) | 14.6 | 12 |
| 2028 | 19.6 bn | 1.9 bn | 1.86 (1.52 / 2.03) | 13.1 | 10 |
Amounts in EUR, the reporting currency.
Track record against expectations: reported EPS above consensus 8 times over the last 12 releases.
Source: ratings and forecasts published by analysts, collected on 07/11/2026. An analyst rating or target is not a guarantee.
Dividends and earnings
Koninklijke Philips N.V.: dividend history, last distributions, stock splits and earnings releases.
Annual dividend per share (EUR), adjusted for splits. Light bar: current year, incomplete. Red bar: lower than the previous year.
Latest ex-dividend dates
| Ex-dividend | Amount | Payment |
|---|---|---|
| 12/05/2026 | 0.850 EUR | 03/06/2026 |
| 12/05/2025 | 0.850 EUR | 06/06/2025 |
| 11/05/2023 | 0.850 EUR | 18/05/2023 |
| 12/05/2022 | 0.787 EUR | 08/06/2022 |
| 10/05/2021 | 0.787 EUR | 09/06/2021 |
| 13/05/2019 | 0.771 EUR | 13/06/2019 |
| 07/05/2018 | 0.726 EUR | 06/06/2018 |
| 15/05/2017 | 0.726 EUR | 09/06/2017 |
Earnings releases
| Date | Published EPS | Expected EPS | Surprise |
|---|---|---|---|
| 27/07/2026 | 0.48 | 0.35 | +39.4 % |
| 06/05/2026 | 0.23 | 0.20 | +13.6 % |
| 10/02/2026 | 0.59 | 0.48 | +25.0 % |
| 04/11/2025 | 0.37 | 0.32 | +15.5 % |
| 28/07/2025 | 0.37 | 0.27 | +34.0 % |
| 07/05/2025 | 0.24 | 0.18 | +31.0 % |
Stock splits
| Date | Operation |
|---|---|
| 09/05/2024 | split: 75,671 shares for 73,171 |
| 11/05/2023 | split: 116,953 shares for 111,953 |
| 30/06/2020 | split: 50 shares for 49 |
| 01/08/2000 | reverse split: 969 share for 1,000 |
| 17/04/2000 | split: 4 shares for 1 |
| 31/05/1999 | reverse split: 23 share for 25 |
Factual data: ex-dividend history and earnings calendar, as of 05/11/2026. A past dividend does not guarantee the next one.
Who owns the stock
Free float, institutional investors, large funds, executives and elected officials: declared positions in Koninklijke Philips N.V.
Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 01/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.
PEA and practical information
Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.
Frequently asked questions about Koninklijke Philips N.V.
What is the Koninklijke Philips N.V. share price?
Latest recorded price: 27.33 EUR on 06/11/2026, for a market cap of 29.8 bn USD.
What is the revenue of Koninklijke Philips N.V.?
19.9 bn USD for fiscal year 2025, with net income of 999 m USD (net margin 5.0 %).
Does Koninklijke Philips N.V. pay a dividend?
Yes. Latest dividend: 0.850 EUR per share, ex-dividend on 12/05/2026. Over 12 months: 0.850 EUR. Yield on the latest known price: 1.5 %.
What do analysts say about Koninklijke Philips N.V.?
Out of 22 analysts: 10 buy or strong buy, 12 hold, 0 sell or strong sell.
What is the P/E ratio of Koninklijke Philips N.V.?
Trailing 12-month P/E of 17.6.
Is Koninklijke Philips N.V. stock eligible for the French PEA?
Likely: the company is headquartered in the European Union or the European Economic Area (ISIN NL0000009538) and the stock is listed on a European exchange. The institution holding the PEA confirms eligibility.
How many employees does Koninklijke Philips N.V. have?
67,247 full-time employees according to the latest published profile.
Who runs Koninklijke Philips N.V.?
Roy Jakobs is the company's chief executive.